Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Diabetic Non-proliferative Retinopathy”

84 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 84 results

Not applicableStudy completedNCT01145599
What this trial is testing

Identifying Progression of Retinal Disease in Eyes With NPDR in Diabetes Type 2 Using Non-invasive Procedures

Who this might be right for
Type 2 DiabetesNon Proliferative Diabetic Retinopathy
European Vision Institute Clinical Research Network 374
Early research (Phase 1)UnknownNCT05695417
What this trial is testing

Study to Evaluate the Safety, Tolerability, and Efficacy of OTX-TKI in Subjects With Moderately Severe to Severe Non-proliferative Diabetic Retinopathy

Who this might be right for
Non-proliferative Diabetic Retinopathy
Ocular Therapeutix, Inc. 21
Very early researchUnknownNCT03025399
What this trial is testing

Clinical Study of Tang Wang Prescription Intervene Diabetic Non-proliferative Retinopathy

Who this might be right for
Diabetic Non-proliferative RetinopathyType2 Diabetes
Fengmei Lian 384
Testing effectiveness (Phase 2)UnknownNCT00849537
What this trial is testing

The Effect of Intravitral Injection of Triamcinolone Combined With Cataract Surgery (Phacoemulsification) on Diabetic Macular Edema and Diabetic Retinopathy

Who this might be right for
Diabetic Retinopathy
Shahid Beheshti University of Medical Sciences
Testing effectiveness (Phase 2)Study completedNCT03197870
What this trial is testing

The TIME-2b Study: A Study of AKB-9778 (Razuprotafib), a Novel Tie 2 Activator, in Patients With Non-Proliferative Diabetic Retinopathy (NPDR)

Who this might be right for
Nonproliferative Diabetic Retinopathy
EyePoint Pharmaceuticals, Inc. 167
Post-approval studies (Phase 4)Study completedNCT02874313
What this trial is testing

CPAP Effect on the Progression of Diabetic Retinopathy in Patients With Sleep Apnea

Who this might be right for
Diabetic RetinopathySleep Apnea
Hospital Universitario La Paz 82
Post-approval studies (Phase 4)UnknownNCT05358080
What this trial is testing

Study to Evaluate Efficacy and Safety of Entelon 50mg in Patients With Non-Proliferative Diabetic Retinopathy

Who this might be right for
Non Proliferative Diabetic Retinopathy
Hanlim Pharm. Co., Ltd. 396
Large-scale testing (Phase 3)Looking for participantsNCT07235085
What this trial is testing

Evaluate the Efficacy and Safety of OTX-TKI (Axitinib Implant) in Participants With Non-Proliferative Diabetic Retinopathy

Who this might be right for
Non-Proliferative Diabetic Retinopathy
Ocular Therapeutix, Inc. 930
Not applicableWithdrawnNCT02309502
What this trial is testing

Panretinal Photo-stimulation in Proliferative Diabetic Retinopathy

Who this might be right for
Severe Non-proliferative Diabetic Retinopathy
Manchester University NHS Foundation Trust
Not applicableEnded earlyNCT03242031
What this trial is testing

Medico-economic Comparison Between Treatment with Panretinal Photocoagulation by Laser in 1 Session Versus 4 Sessions in Diabetic Retinopathy

Who this might be right for
Diabetic Retinopathy
Centre Hospitalier Universitaire Dijon 48
Not applicableStudy completedNCT05543564
What this trial is testing

Prophylactic PRP in Moderate NPDR

Who this might be right for
Eye DiseasesDiabetesDiabetic Retinopathy
Assiut University 68
Testing effectiveness (Phase 2)Study completedNCT04692688
What this trial is testing

Study of the Safety and Efficacy of APX3330 in Diabetic Retinopathy

Who this might be right for
Diabetic RetinopathyDiabetic Macular EdemaNPDR - Non Proliferative Diabetic Retinopathy+1 more
Ocuphire Pharma, Inc. 103
Testing effectiveness (Phase 2)Study completedNCT01295775
What this trial is testing

Diabetic Retinopathy Sulodexide Study

Who this might be right for
Diabetic Retinopathy
Ajou University School of Medicine 127
Post-approval studies (Phase 4)Enrolling By InvitationNCT06191094
What this trial is testing

Pre-operative Vabysmo in Patients With Non-clearing Vitreous Hemorrhage Secondary to Proliferative Diabetic Retinopathy

Who this might be right for
Diabetic RetinopathyVitreous Hemorrhage Due to Diabetes Mellitus
University of Colorado, Denver 100
Large-scale testing (Phase 3)Ended earlyNCT05066230
What this trial is testing

Evaluate the Efficacy and Safety of Intravitreal KSI-301 in Non-proliferative Diabetic Retinopathy (NPDR)

Who this might be right for
Non-proliferative Diabetic Retinopathy
Kodiak Sciences Inc 253
Not applicableLooking for participantsNCT06713720
What this trial is testing

Remote Ischemic Conditioning for Non-Proliferative Diabetic Retinopathy

Who this might be right for
Diabetic RetinopathyNon-Proliferative Diabetic RetinopathyRemote Ischemic Conditioning+2 more
Xuxiang Zhang, MD 68
Testing effectiveness (Phase 2)Looking for participantsNCT07354477
What this trial is testing

Single-site Pilot Study Evaluating the Effect of QLS-111 Ophthalmic Solution on Posterior Perfusion and Vessel Dilation

Who this might be right for
Non-proliferative Diabetic Retinopathy (NPDR)Open-angle Glaucoma (OAG)Normal Tension Glaucoma (NTG)
Qlaris Bio, Inc. 14
Not applicableNot Yet RecruitingNCT05852132
What this trial is testing

Clinical Study on Prognosis of Patients With Severe NPDR Undergoing Vitrectomy

Who this might be right for
Non Proliferative Diabetic Retinopathy(NPDR)
Fei Gao 249
Post-approval studies (Phase 4)Study completedNCT07230184
What this trial is testing

To Evaluate the Efficacy and Safety of Combination Therapy With B55R1 and B55R2 Compared to B55R1 Monotherapy in Patients With NPDR

Who this might be right for
Non-Proliferative Diabetic Retinopathy
AJU Pharm Co., Ltd. 52
Post-approval studies (Phase 4)Looking for participantsNCT06662994
What this trial is testing

High Dose Aflibercept in Diabetic Macular Edema in Patients With Previous Vitrectomy

Who this might be right for
Diabetic Macular Edema (DME)
Retina Consultants of Orange County 15
Load More Results